|
|
Volumn 7, Issue 1, 2003, Pages 21-29
|
|
Cyclooxygenase-2: from arthritis treatment to new indications for the prevention and treatment of cancer.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITOR;
ISOENZYME;
MEMBRANE PROTEIN;
NONSTEROID ANTIINFLAMMATORY AGENT;
PROSTAGLANDIN SYNTHASE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
PTGS2 PROTEIN, HUMAN;
CONTROLLED CLINICAL TRIAL;
DOSE RESPONSE;
DRUG ADMINISTRATION;
DRUG EFFECT;
ENZYMOLOGY;
FEMALE;
FOLLOW UP;
HUMAN;
LONG TERM CARE;
MALE;
METABOLISM;
NEOPLASM;
NURSING;
REVIEW;
RHEUMATOID ARTHRITIS;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ARTHRITIS, RHEUMATOID;
CONTROLLED CLINICAL TRIALS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
ISOENZYMES;
LONG-TERM CARE;
MALE;
MEMBRANE PROTEINS;
NEOPLASMS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
SENSITIVITY AND SPECIFICITY;
TREATMENT OUTCOME;
|
|
EID: 0037267598
PISSN: 10921095
EISSN: None
Source Type: Journal
DOI: 10.1188/03.CJON.21-29 Document Type: Review |
|
Times cited : (11)
|
|
References (71)
|
